# A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

> **NCT03766581** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 2366 (actual)

## Conditions studied

- Acute Ischemic Stroke
- Transient Ischemic Attack (TIA)

## Interventions

- **DRUG:** BMS-986177
- **OTHER:** Placebo
- **DRUG:** Clopidogrel
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT03766581
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-27
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 2366 (ACTUAL)
- **Last updated:** 2023-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03766581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03766581, "A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03766581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*